We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Low Radiation Doses in Nature May Pose Risk

By Biotechdaily staff writers
Posted on 20 May 2002
A study has found that radiation can trigger widespread mutations in living cells at much lower doses than previously thought possible. More...
Conducted by researchers at Columbia University College of Physicians and Surgeons (New York, NY, USA), the study was published in the December 4, 2001, issue of the Proceedings of the National Academy of Sciences.

The study found that a dose that strikes as few as one in 10 cells has nearly the same mutagenic effect as a dose that strikes every cell. The added damage occurs because of what is called the "bystander effect,” in which injured cells send aberrant signals to neighboring cells. This effect occurs with alpha particles, which come from such sources as nuclear explosions, plutonium, and radon, a naturally occurring gas that seeps into many homes.

The risks of exposure to lower radiation levels are poorly understood and have been the subject of controversy for decades, say the researchers. In the study, they found that when they beamed alpha particles at only one in 10 cells, the results were almost the same as if they had beamed them at all cells. Nearly all the cells showed mutations in their DNA. However, the researchers found they could prevent widespread damage by blocking the signaling network that exists between cells. By using chemicals that obstruct key cell-to-cell pathways, the researchers could restrict the damage to the 10% of cells that had directly received alpha particles. This suggests that signaling networks are responsible for spreading the damage, but little is known about the signaling mechanism at this time.

Previously, public health officials have assumed the risk of radiation is proportional to the dose. Lower doses carry lower risk. The new findings suggest such a linear relationship might not be operating. Instead, the study suggests that at low doses, the risk rises steeply in proportion to the dose, while at higher doses, the risk rises more gently in relation to the dose.

According to Dr. Howard L. Liber, associate professor of radiobiology at Harvard School of Public Health, the study is "another piece of hard evidence to suggest we may need to reassess acceptable radiation levels.”


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Serum Indices Control
Acusera Serum Indices Control
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
Manual Pipetting Aid
Pipette Controllers macro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Dr. Olivia Belbin, head of the Molecular Neurodegeneration Group at IR Sant Pau and study corresponding author, with Alba Cervantes (right), first author and IR Sant Pau researcher (Photo courtesy of IR Sant Pau)

Blood Biomarker Detects Alzheimer’s Changes Decades Before Symptoms in Down Syndrome

Alzheimer’s disease can begin altering the brain long before clinical symptoms appear, creating a challenge for early-stage detection and research. People with Down syndrome face a particularly high age-related... Read more

Molecular Diagnostics

view channel
Photo courtesy of National Human Genome Research Institute

Genomic Screening Expands Detection of Treatable Conditions in Newborns

Conventional newborn screening can miss conditions that lack biochemical biomarkers or present atypically. Initial hearing screens may also fail to detect hearing loss that is later identified through... Read more

Microbiology

view channel
Image: Invasive aspergillosis (IA) is a potentially life-threatening infection caused by Aspergillus mold that primarily affects people with severely weakened immune systems. (Image Credit: Adobe Stock)

Rapid Urine Test Aids Diagnosis of Invasive Aspergillosis

Invasive aspergillosis is an uncommon mold infection in the general population but can pose serious risks for people with weakened immune defenses. Diagnosis can be difficult because existing approaches... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: NMPA approvals for Quanterix HD-X and SR-X instruments and four neurology biomarker assays expand access to ultrasensitive blood-based testing in China (Photo courtesy of Quanterix Corporation)

Regulatory Milestone Expands Access to Blood-Based Neurology Biomarker Testing in China

Quanterix Corporation (Billerica, MA, USA) and Innovita Biological Technology Co., Ltd. (Beijing, China) announced regulatory approvals that expand access to Quanterix SIMOA technology and neurology biomarker... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.